PTW-FREIBURG is recalling its VERIQA software (versions 2.0 and 2.1) because the system may incorrectly calculate the 'Gamma Passing Rate' when certain dose thresholds are excluded. This defect can lead to an overestimation of the passing rate, potentially resulting in false-positive evaluations for medical treatment plans. Approximately 65 units are affected worldwide, including one unit distributed in Georgia. Consumers should contact their healthcare provider or the manufacturer immediately for guidance on software updates or alternative verification methods.
The software may report that a radiation treatment plan is accurate when it actually contains errors. This overestimation could lead to patients receiving incorrect radiation doses during oncology treatments, potentially impacting the safety and effectiveness of the therapy.
Manufacturer notification and guidance
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.